<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BIOR
Biora Therapeutics
$
()


  • Biora Therapeutics: FDA clears IND application for BT-600

    11/30/2023 - 16:49pm
  • Biora Therapeutics submits updated IND application for BT-600 'as planned'

    10/30/2023 - 16:33pm
  • Biora Therapeutics to submit updated IND application for BT-600

    10/23/2023 - 17:31pm
  • Biora Therapeutics presents data on BioJet systemic oral delivery platform

    10/5/2023 - 08:06am
  • Biora Therapeutics price target lowered to $50 from $65 at H.C. Wainwright

    10/2/2023 - 06:08am
  • Biora Therapeutics submits IND application to FDA for BT-600 program

    9/25/2023 - 08:05am
  • Biora Therapeutics enters agreement with certain Athyrium Capital funds

    9/19/2023 - 08:13am
  • Biora Therapeutics achieves performance targets for BioJet platfor

    9/5/2023 - 08:07am
  • Biora announces new patents covering its BioJet Systemic oral delivery platform

    8/3/2023 - 08:21am
  • Biora announces clinical device performance study results for NaviCap

    7/27/2023 - 08:15am
  • Biora Therapeutics to sell legacy diagnostics assets, terms not disclosed

    7/5/2023 - 08:02am
  • Biora Therapeutics announces new patents for its NaviCap platform

    6/28/2023 - 08:37am
  • Biora presents data on BioJet Oral Biotherapeutic Delivery Platform

    6/26/2023 - 06:03am
  • Biora Therapeutics announces $8.0M registered direct offering

    6/13/2023 - 08:11am
  • Biora Therapeutics appoints Kelman as Chief Medical Officer

    5/1/2023 - 09:04am
dynamic_feed Breaking News